Engineering retroviruses into vectors of therapeutic value has been a highly pursued effort. To date, the promise of retroviral-mediated gene delivery to treat or even cure genetic diseases has been ...
A recent clinical trial in two adult X-CGD patients incorporated partially ablative busulfan conditioning before the infusion of autologous CD34+ cells transduced with the SF71gp91 phox γ-retroviral ...